.svg){kind=small}
Jul-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Maven Genetics is stocked at 523 licensed dispensaries across California and Oklahoma, 522 of them in California, with the deepest coverage in Los Angeles, San Diego, Sacramento, Santa Ana, and Costa Mesa. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
Maven Genetics concentrated 57.27% of July 2026 sales in Flower, up 3.24% month over month and 24.03% year over year, while Vapor Pens reached a 21.37% share with 12.92% MoM and 78.61% YoY growth; Pre-Roll matched with a 21.22% share on 3.75% MoM and 169.64% YoY expansion. Concentrates contracted to 0.14% share with -34.66% MoM and -84.68% YoY declines, and the brand’s average price fell 22.20% YoY even as total brand sales rose 49.39% YoY, indicating a volume-led mix. The pattern implies Maven Genetics is pivoting toward scaled, lower-price velocity in Flower and format diversification into Vapor Pens and Pre-Roll, using price to gain share while exiting underperforming Concentrates.
With Flower still the anchor at 57.27% and a Flower rank of 18 in California, the 12.92% MoM acceleration in Vapor Pens and 3.75% MoM lift in Pre-Roll suggest a flanking strategy to capture adjacent inhalable occasions as the 22.20% YoY price decline broadens access. The combination of 78.61% YoY growth in Vapor Pens and 169.64% YoY growth in Pre-Roll, against a shrinking 0.14% Concentrates footprint, implies positioning around mainstream, high-frequency formats where price elasticity converts to share, rather than premium niche extracts.
Competitive Landscape
Maven Genetics sits at rank #18 in California Flower for July 2026, improving 7 positions from #25 year over year, and holding flat versus April 2026 at #18, while STIIIZY advanced from #2 to #1 with a 59.7% year-over-year sales increase and CannaBiotix (CBX) slipped from #1 to #2 despite a 7.0% gain; meanwhile, CAM climbed from #4 to #3 with 52.2% growth as Claybourne Co. fell from #3 to #5 with a 1.4% decline, indicating Maven Genetics’ rise to a new peak rank (#18 in July 2026) is tied more to steady positioning amid competitor churn than to outsized category momentum, which implies a path of incremental share capture rather than breakout displacement of top-three incumbents.
Notable Products
Lemon Cherry Tropicana Pre-Roll (1g) led the downturn with a -26.7% month-over-month decline in July 2026 while sliding to rank 6, and Umami Butter (3.5g) fell -25.3% at rank 7, signaling pressure on both Pre-Roll and Flower. In contrast, Black Lotus (3.5g) climbed +23.8% to rank 3, and Bluzangria Pre-Roll (1g) grew +18.9% to hold rank 1, indicating gains are concentrated in a few leaders while mid-pack SKUs retreat. With Flower occupying three of the top ten and Pre-Rolls taking two slots including the top position, the mix tilts toward inhalables where volatility is creating room for targeted hero-SKU investment rather than broad catalog push.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
